Form 4: Orthopediatrics Corp CEO David R. Bailey Reports Stock Transactions
SEC Form 4 Filing
David R. Bailey, CEO of Orthopediatrics Corp, reports acquisition and disposal of company stock, including sales to cover tax obligations.
Summary
- On March 15, 2025, David R. Bailey acquired 97,496 shares of Orthopediatrics Corp common stock at $0.
- On March 18, 2025, Bailey sold 6,620 shares of common stock at $24.86 per share.
- Following these transactions, Bailey directly owns 319,155 shares of Orthopediatrics Corp.
- The sale of shares was to satisfy tax withholding obligations upon the vesting of restricted shares.
- The reported holdings include 232,335 restricted stock awards.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of stock transactions. The sale to cover taxes is a common practice.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common in the healthcare industry.
Stakeholder Impact
- The stock sale could have a minor impact on shareholders, but it's primarily related to tax obligations of the CEO.
Key Dates
| Date | Description |
|---|---|
| 03/15/2025 | Acquisition of 97,496 shares of common stock. |
| 03/18/2025 | Sale of 6,620 shares of common stock at $24.86 per share. |
| 03/18/2025 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.